Leukocyte telomere length: the dawn of a new era of personalised medicine in fibrotic interstitial lung diseases?

Tweetable abstract

Leukocyte telomere length will be a biomarker applied to precision medicine. When <10th percentile, it is associated with increased risk of mortality in patients with fibrotic hypersensitivity pneumonitis or unclassifiable ILD exposed to immunosuppression.https://bit.ly/46TwAtv